Clinical Trial Update: AraC for Newly Diagnosed Adult Langerhans Cell Histiocytosis [Phase 2]

View source ↗

Summary

Phase 2 trial update for AraC in newly diagnosed adult Langerhans Cell Histiocytosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Langerhans Cell Histiocytosis

Drugs mentioned

• AraC (cytarabine)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Langerhans Cell Histiocytosis | Phase 2 | Status: UNKNOWN